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Abstract: With state-of-the-art microarray technologies now available for whole genome CpG island (CGI) methylation 
proﬁling, there is a need to develop statistical models that are speciﬁcally geared toward the analysis of such data. In this 
article, we propose a Gamma-Normal-Gamma (GNG) mixture model for describing three groups of CGI loci: hypomethyl-
ated, undifferentiated, and hypermethylated, from a single methylation microarray. This model was applied to study the 
methylation signatures of three breast cancer cell lines: MCF7, T47D, and MDAMB361. Biologically interesting and in-
terpretable results are obtained, which highlights the heterogeneity nature of the three cell lines. This underlies the premise 
for the need of analyzing each of the microarray slides individually as opposed to pooling them together for a single analy-
sis. Our comparisons with the ﬁtted densities from the Normal-Uniform (NU) mixture model in the literature proposed for 
gene expression analysis show an improved goodness of ﬁt of the GNG model over the NU model. Although the GNG 
model was proposed in the context of single-slide methylation analysis, it can be readily adapted to analyze multi-slide 
methylation data as well as other types of microarray data.
Keywords: CpG islands, mixture modeling, methylation/epigenetic signature, microar  rays, breast cancer cell lines.
1. Introduction
Mammalian DNA methylation occurs when a methyl group is added to the cytosine residue of a CpG 
dinucelotide (Jaenisch and Bird, 2003) and indeed a large portion of genomic DNA is methylated in 
CpG dinucleotides. Essential exceptions are the CpG islands (CGIs) within gene promoters that are 
generally unmethylated in normal cells. For more than two decades it has been known that DNA meth-
ylation is associated with gene activity and chromatin structure. Recent studies have demonstrated that 
aberrant CpG methylation is connected to human diseases such as cancer (Laird, 2005; Yang et al. 2006; 
Wang et al. 2006), Niemann-Pick Disease (Simonaro et al. 2006), lupus (Ballestar et al. 2006; Patole 
et al. 2005), and Rett syndrome (Kriaucionis and Bird, 2003).
Implementation of state-of-the-art microarray technologies has made possible the mea  surement of 
the methylation signature of multiple genes simultaneously (Piotrowski et al. 2006; Shen et al. 2006; 
Yan et al. 2002). Methylation signatures, and more generally epi  genetic signatures, play an important 
role in furthering the system-wide understanding of the biological mechanism of disease. Recently, 
groups have conceptualized, and in a small part realized, the idea of a human epigenome project (Jones 
and Martienssen, 2005; Rakyan et al. 2004). As the human genome project has advanced discoveries 
in both basic and translational science, it is expected that the human epigenome project combined with 
high-throughput methylation assays will facilitate our fundamental understanding of aberrant epigenetic 
mechanisms.
Two aspects of microarray data make the analysis exceptionally challenging. First, even with recent 
advances in the microarray technology, there exists experimental variability, which makes detection of 
genuine biological differences diﬁ  cult to accomplish as the two may be confounded (Verducci et al. 44
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2006). Second, if p genes are measured in the 
microar  ray experiments, then the microarray data 
represents a p-dimensional random vector with 
mutually dependent components. Cost, both 
monetary and temporal, make it inhibitive to 
generate more than a small number (with respect 
to p) of replicates. This “large-p-small-n” scenario 
prevents the use of classical statistical approaches 
to data analysis (Verducci et al. 2006).
In some circumstances microarray analysis is 
further hampered by the lack of any ex  perimental 
or biological replicates. Note that a single-slide 
analysis (n = 1), when there is no replication at all, 
is the “large-p-small-n” scenario taken to the 
extreme. This may be due to lack of resources (such 
as time, biological samples, arrays, etc.) for a larger 
experimental study. For example, a pilot study may 
be interested in the epigenetic differences between 
tumors in different stages of progression; however, 
due to limited ﬁnancial resources only one sample 
from each stage is assayed. Once the human epig-
enome project is completed, another conceivable 
situation is the clinical application of high-
throughput arrays for assaying the methylation 
signature of DNA markers associated with different 
diseases. Gene expression data from microarrays 
has recently been used to model interactions of 
multiple risk factors associated with clinical 
outcome for use in individual patient care (Potti 
et al. 2006; Li, 2006; Pittman et al. 2004). The 
integration of genome wide methylation informa-
tion from a single slide patient sample will poten-
tially enhance and strengthen the clinical predictive 
power of such risk models (West et al. 2006).
A number of methods have been suggested for 
ﬁnding genes that are differentially ex  pressed 
between two variants for single-slide data, all of 
which are proposed for gene ex pression microarray 
data. The most common approach is to ﬂag those 
with an intensity ratio above a given cut-off, typi-
cally between 1.5 and 3. Such a selection criterion 
is ad-hoc in nature. More formal statistical treat-
ments are available in the literature. Newton et al. 
(2001) suggested modeling the Cy5 and Cy3 
signals on an array as independent random vari-
ables each following a gamma distribution. Such 
an approach beneﬁts from considering the thou-
sands of measurements on an array simultaneously 
rather than individually (Efron and Morris, 1973; 
Carlin and Louis, 1996). A different single-slide 
applicable approach was recently proposed by 
Dean and Raftery (2005), which models the 
normalized log intensity ratios as coming from a 
two-component, Normal and Uniform (NU), 
mixture of distributions.
In this paper, we present a methodology for 
the detection of differentially methylated loci 
between the two samples co-hybridized onto a 
methylation microarray. The log ratio of the Cy5 
to Cy3 intensities of the probes on the array are 
modeled as random variables sampled from one 
of three distributions. These three groups are 
biologically interpreted as hypomethylated: the 
assayed DNA from the Cy3 sample is methylated 
while the Cy5 sample is not; hypermethylated: 
the Cy5 sample is methylated and the Cy3 sample 
is not; and undif ferentiated: there is no observable 
difference in methylation status between the two 
samples. This model was applied to three breast 
cancer cell lines, MCF7, T47D, and MDAMB361. 
These analyses yielded biologically meaningful 
results, which are consistent with the current 
understanding of the role of aberrant methylation 
in breast cancer development. A boot strap resampling 
technique was used to evaluate the reliability of 
the probe classiﬁcations from the ﬁtted model. 
We further assessed the goodness of ﬁt of this 
model by comparing it to that of the NU model 
(Dean and Raftery, 2005) based on the Kullback-
Leibler distance measure.
2. Methods
In this section we ﬁrst introduce a mixture model 
for identifying differentially methylated loci 
(probes) in the sample. An algorithm is described 
for estimating the parameters of the model. Then, 
we outline the usage of the model for classifying 
the probes into the three groups: hypomethylated, 
undifferentiated, and hypermethylated.
2.1. Gamma-Normal-Gamma 
mixture model
Consider the Red (R; Cy5) and Green (G; Cy3) 
intensity measurements. Our interest is to model 
Y, the normalized log ratio, log2(R/G), by the 
Gamma-Normal-Gamma (GNG) model. Our 
assumption here is that certain steps have already 
been taken to normalize the data ﬁrst. Brieﬂy, 
loess normalization transform as described in 
(Yang et al. 2002) is applied to the data, however, 
the loess ﬁt is based on a rank-invariant subset as 
in (Speed, 2003).45
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We begin by modeling probes as three different 
groups: hypomethylated, undifferenti  ated, and 
hypermethylated. Since the undifferentiated probes 
have a true log ratio of zero, we model the observed 
log ratio for these probes by a Normal distribution. 
For the hyper-methylated probes, the log ratio will 
be positive and hence a Gamma distribution will be 
a reasonable choice for modeling this group of 
probes. The choice of the Gamma model is mainly 
due to the perception that the characteristics of the 
distribution match well with the biological data it 
models. In fact, the Gamma model has a long history 
in statistical ecology (e.g. Fisher et al. 1943) due to 
both its analytical convenience and its possession of 
a potential deeper biological interpretation, and it 
has recently been used in microrray analysis (Newton 
et al. 2001). The log ratios corresponding to the 
hypomethylated probes are negative, and we choose 
to use the mirror image of the Gamma distribution 
used for the hypermethylated probes for this group 
of probes. However, we choose a different set of 
parameters for the mirror image Gamma distribution. 
Thus, overall, a mixture of three distributions, that 
is, one Normal and two different Gamma distribu-
tions will be used to model the normalized log ratio 
Y. Mathematically, the model is given as follows.
Consider the indicator function I{y  >  0} = 1, for 
y > 0, and zero otherwise. Our proposed mixture 
model is then given by
 f  (y; Ψ) = π1 G(−y; α1, β1) I {−y>0}   
 +  π2 N(y; μ, σ
2)  
 +  π3 G(y; α2, β2) I{y>0}  (1)
where πk > 0, k = 1, 2, 3, are called mixing propor-
tions, and they represent the proportion of each of 
the three above mentioned groups, and further 
Σk=1
3 πk = 1. The G(·; α, β) and N(·; μ, σ
2) stand 
for the Gamma and Normal density functions, and
 Ψ   = (α1, β1, α2, β2, μ, σ
2, π1, π2 , π3) 
is the vector of all unknown parameters in the 
model, but note that the π’s are interdependent. In 
(1), the π1 and π3 show the probabilities of each 
probe being hypomethylated and hypermethylated, 
respectively. The π2 is the probability that a probe 
is not differentially methylated. Although the theo-
retical mean of the normal component is zero, we 
opted to allow this value to be estimated jointly 
with the other parameters to capture any residual 
bias that has not been removed by normalization.
2.2. Parameter estimation
Since our modeling approach is fully parametric, 
we use the most popular parameter esti  mation 
method, that is maximum likelihood estimation, 
for estimating the parameter vector Ψ.
Let yi, i = 1, 2, ..., n, be the normalized log ratios. 
The log-likelihood function of the parameter vector 
Ψ is given by
 l n(Ψ) =  log f
i
n
= ∑
1
( yi; Ψ)  
where f (yi; Ψ) is the mixture density function in 
(1). The Maximum Likelihood Estimate (MLE) of 
Ψ is then given by
  ˆ argmax ( ) ΨΨ
Ψ
nn l = . 
Due to the complexity of the log-likelihood 
function ln(Ψ), there is no apparent analytical form 
for the estimator  ˆ Ψn. Thus a numerical method is 
needed to ﬁnd the solution to the above maximiza-
tion problem. In the context of mixture models, the 
Expectation-Maximization (EM) algorithm of 
Dempster, Larid and Rubin (1997) provides a 
convenient approach to obtain the MLE  ˆ Ψn. The 
EM algorithm in our problem is outlined as 
follows.
Let zik, k = 1, 2, 3, be indicator variables 
showing the component membership of each 
observation yi in the mixture model (1). Note that 
zik’s are unobservable (missing) variables. The 
EM algorithm works with the complete data log-
likelihood function
 
lz
zG y
n
c
i
k i
n
ii
() l o g
log[ ( ; ,
Ψ =
+−
= = ∑ ∑ kk
1
3
1
1
π
αβ 11 1
μ
)]
log[ ( ; )]
lo
{} {
+
+
−>
= ∑ I
zN y
z
y
i
n
ii
i
i 0
1
2
3
,
2 σ
g g[ ( ; )] . {} Gy I iy i αβ 22 , > } 0
 
The EM algorithm ﬁnds  ˆ Ψn iteratively in two steps 
as follows.
E-Step: Let Ψ
(m) be the estimate of Ψ after the mth 
iteration. The E-step computes the conditional 
expectation of the function ln
c(Ψ) with respect to 
P (z | y, Ψ
(m)), where z = {zik, i = 1, ···, n, k = 1, 2, 3.}, 46
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and y = {y1, ···, yn}. The conditional expectation is 
found to be
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are the conditional expectations of the zik’s.
M-Step: The M-step on the (m+1)th iteration 
maximizes the function Q(Ψ; Ψ
(m)) with respect to 
Ψ. By maximizing this function with respect to 
πk’s, μ and σ
2, we have
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Maximization with respect to (αk, βk), k = 1, 2, needs 
to be done by using a numerical method. In the current 
study we used the function optim( ) in R for this task. 
This function implements the method of Nelder and 
Mead (1965) to maximize the objective function. 
Starting from an initial value Ψ
(0), the EM algo-
rithm iterates between the E and M-steps until 
some convergence criterion is satisﬁed. For 
example, for a pre-speciﬁed value ε > 0, the algo-
rithm will stop if
 ||  Ψ
(m+1)−Ψ
(m) || <
 ε. 
This was the criterion used in the analyses carried 
out in this paper, with ε = 10
−12 and the use of the 
L
2 norm.
Due to the sensitivity of the results to the choice 
of starting point, it is recommended that multiple 
sets of random and non-random initial parameter 
values be used to increase the chance of ﬁnding 
the global maximum, especially if the likelihood 
surface is multimodal. For our applications, we 
used 20 sets of starting values; the estimates that 
led to the maximum likelihood were taken as our 
MLE.
2.3. Classiﬁcation
Finite mixture models provide a model-based 
approach for classiﬁcation (McLachlan and Peel, 
2000). Consider a ﬁnite mixture model with K 
components which in fact corresponds to K classes. 
In the model-based classiﬁcation one ﬁrst calcu-
lates the posterior probability that an observation 
belongs to any of the classes k = 1, 2, ..., K. Then 
the observation is classiﬁed into the class with 
highest posterior probability. Accordingly, the 
classiﬁcation based on the GNG mixture model 
can be performed as follows.
Consider the log ratios Yi, i = 1, 2, ..., n, that are 
assumed to follow the GNG mixture model in (1). 
The posterior probabilities that Yi belongs to any 
of the classes 1, 2 or 3 are given by
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Using the MLE  ˆ Ψn , let  ˆ pik, k = 1, 2, 3, be the 
MLE’s of the posterior probabilities. A probe with 
log ratio Yi is classiﬁed to class k if
  ˆ max{ˆˆˆ }. ,, , , pp p p ik i i i max = 123 
To increase one’s conﬁdence on the probes 
classiﬁed, especially those labeled as differentially 
methylated, and to guard against false positives, 47
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we decided to classify a probe with log ratio Yi to 
class k only if
 
ˆ
ˆ
, p
p
C
ik
ij
max >  
for some constant value C ≥ 1, for all j ≠ k; other-
wise that particular probe is left as unclassiﬁed. 
We suggest to set the value of C to be inversely 
related to the conﬁdence of the technology gener-
ating the data. That is, a small value for C should 
correspond to a high conﬁdence in the sensitivity 
and reproducibility of the microarray measure-
ment. In the applications to the three cell lines, a 
value of 2 was chosen for C to reﬂect our degree 
of conﬁdence in the microarray experiments, which 
was also partly motivated by ease of interpretation: 
a two-fold difference in probabilities was required 
to determine classiﬁcation. In the situation where 
a priori information about the quality of the micro-
array measurement is unavailable, a bootstrap 
technique as described below may be used as a 
means to select an appropriate C that will lead to 
high consistency rates.
3. Results
3.1. Breast cancer data
Three cell lines. Breast cancer cell lines have been 
used as research models for a long time. A large 
number of them were established in the late 1970s. 
Two of the cell lines we chose to analyze, MCF7 
and T47D, are among the most often studied breast 
cancer cell lines. They share distinctive features 
such as isolated originally from pleural effusions, 
little to no invasiveness, hormone-receptor 
(estrogen-and progesterone receptor) positive, 
Her-2/neu negative, expression of WNT7B onco-
gene, and high expression of genes associated with 
the luminal epithelial-like phenotype. Although 
there are many similarities between these two cell 
lines, there also exist differences. First, the age of 
the patients from which these two cell lines derived 
from were 69 and 54 for MCF7 and T47D, respec-
tively. As DNA methylation increases with age, we 
would expect more methylation events in samples 
from older patients. Second, though both of these 
cell lines express estrogen receptor, it was noted 
by Karey and Sirbasku (1988) that they responded 
differently to the challenge of 17 beta-estradiol. 
Third, due to known (caspase 3 is expression in 
T47D but not in MCF7) and unknown gene expres-
sion proﬁles associated with the cell lines, they 
were shown to respond differently to gene pertur-
bation (Yamashita et al. 2003) and to drug- and 
chemical treatments (Green, 2003; Bhat, 2001). 
Although the MDA-MB-361 cell line shares only 
one common feature with the other two cell lines 
(positive hormone receptor status) and has many 
distinct features (isolated originally from a brain 
metastasis of a 40 years old patient, moderate in 
vitro invasiveness, Her-2/neu overexpression, and 
expression of WNT7H + oncogene), it still tends 
to be closer to the luminal epithelial-like MCF7 
and T47D than to the mesenchymal-like breast 
cancer cell lines. In all, we expect these three cell 
lines to share some commonly methylated loci and 
harbor aberrant methylation in loci that were 
uniquely theirs.
Generation of methylation proﬁles. The array 
employed to generate the methylation proﬁles for 
the three cell lines was custom designed to assay 
the promoter regions located within a CpG island 
(regions of the DNA with higher than expected 
CpG dinucleotides). The oligonucleotide probes 
printed on the array were selected from a larger 
library of probes comprising Agilent’s location 
analysis array (Boyer et al. 2005). Oligonucleotide 
probes were considered if their target was located 
within the predicted promoter region of a gene. 
This subset was further reduced so that the resulting 
array contained 40659 unique probes with targets 
located within the predicted promoter region of 
10834 unique genes. For each cell line, DNA was 
isolated from the cells, digested by the restriction 
enzyme BfaI in order to reduce genomic complexity, 
and ligand linked for subsequent PCR. Methylation 
sensitive enzymes, HpaII and HinP I1, were used 
to interrogate the methylation status of the DNA 
fragments. The remaining intact DNA was then 
PCR ampliﬁed, dye coupled with either Cy5 
(cancer samples) or Cy3 (normal samples), and 
hybridized onto the CpG promoter methylation 
array as described above. Thus, we have a total of 
three slides, each captures the methylation signa-
ture of a particular cell line. In all three slides, the 
normal samples come from the immortalized 
normal breast epithelial cell line MCF10A.
Data preprocessing. By utilizing the ink jet 
technology, Agilent has eliminated spatial effect 
often found correlated with print-tip regions on 
other oligo arrays. Upon inspection of the heat map 
for the normalized log-ratio of the probes with 48
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respect to their position on the array, see Figure 1, 
no obvious spatial effects were apparent. There-
fore, no spatial correction was made. However, 
Figure 2, A–C show a signiﬁcant, yet typical, dye 
effect, and thus the data were normalized as 
described above. Since the spread of the resulting 
mean-corrected log-ratios was not signiﬁcant 
(0.33 ± 0.03), no methods for adjusting the spread 
of the data was used (see Figure 2, D–F).
3.2. Model ﬁtting
We ﬁtted the GNG model to the normalized data 
form the three microarray experiments. The param-
eter estimates corresponding to each experiment are 
given in Table 1. For all three cell lines, the mixing 
proportions follow approximately a 15-70-15% 
split, although deviations among one another is 
obvious. Similar observations apply to the 
estimates of the other parameters. In particular, we 
note that the mean estimates for the normal compo-
nent are all close to 0, as one would expect with 
the normalized data, but the three estimates deviate 
from one another. To check the performance of the 
ﬁtted GNG model empirically, we plotted the 
density function of the ﬁtted models over the histo-
grams of the normalized log ratios. Furthermore, 
QQ-plots are also provided. As can be seen from 
Figure 3, apart from a few points at the end of the 
QQ plots not falling right on the straight lines, the 
plots show that the GNG model provided reason-
ably good ﬁts to each of the microarray data. Using 
the classiﬁcation criterion discussed in 2.3, probes 
were classiﬁed as hypermethylated (red dots in 
Figure 2, D–F), undifferentiated (black dots), 
hypomethylated (green dots), or left unclassiﬁed 
(blue dots). This resulted in a total of 965, 1051, 
and 375 genes, in MCF7, T47D, and MDAMB361, 
Table 1. Parameter Estimates in the Three Experiments.
Estimates MCF7  T47D  MDAMB361
(α ˆ1, β ˆ1)  (0.94, 0.42)  (1.07, 0.31)  (0.95, 0.37)
(μ ˆ, σ ˆ)  (0.002, 0.24)  (–0.01, 0.21)  (0.01, 0.20)
(α ˆ2, β ˆ2)  (1.11, 0.31)  (0.93, 0.36)  (0.91, 0.24)
(π ˆ1, π ˆ2, π ˆ3)  (0.16, 0.68, 0.16)  (0.13, 0.73, 0.15)  (0.16, 0.71, 0.14)
Spatial : Rank(M-Norm) Spatial : Rank(M-Norm) Spatial : Rank(M-Norm)
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Figure 1. Heat map for the normalized log-ratio of the Cy5 to Cy3 intensity for the three analyzed data sets. Color scheme represents rela-
tive ranking of the log-ratio with green denoting a low ranking, or relatively small ratio, and red denoting a high ranking, or relatively large 
ratio. The x and y axis of the plots denote the position of the probe on the microarray.49
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respectively, labeled as hypermethylated, the group 
that we will focus on in discussing the biological 
relevance in the next sub-section.
Despite the fact that we know there are three 
groups of probes: hypomethylated, hyper-methylated 
and undifferentiated, one may also consider ﬁtting 
the NU model (Dean and Raftery, 2005), which was 
proposed to identify differentially expressed genes 
from non-differentially expressed ones. To compare 
the relative goodness of ﬁts of the GNG and the NU 
models to each of the dataset, we use the Kullback-
Leibler (K-L) distance. In proba  bility and informa-
tion theory, the Kullback-Leibler distance ( or relative 
entropy) is a natural distance measure between two 
probability distributions with densities functions, 
say, f (x) and g (x), and is deﬁned as
  KL f g f y
fy
gy
dy (,) () l o g
()
()
. =
-•
+•
Ú  (2)
The K-L distance is always non-negative, and 
KL(f, g) = 0 if and only if f = g. In applications, 
typically f represents the empirical distribution of 
the observed data, and g represents a proposed 
approximation of f. In the current application, the 
proposed GNG or the NU mixture plays the role 
of g, after the ﬁtted density is discretized, and thus 
(2) becomes a summation. Table 2 shows the K-L 
distance based on each of the GNG and NU mixture 
models as well as a measure of reduction of 
distance, for each the three experiments under 
consideration. As we can see from the table, the 
KL distances are much larger under the NU model 
than under the GNG model.
We further investigated the reliability of the 
GNG model for classiﬁcation using a boot  strap 
resampling technique. For each of the three exper-
iments under study, we generated a bootstrap 
sample in each experiment and re-classiﬁed the 
Table 2. Kullback-Leibler Distance Between the Fitted Models (GNG or NU) and the Ob  served Data.
K-L Distance  MCF7  T47D  MDAMB361
KL(GNG, Obs.)  0.00055  0.00047  0.00086
KL(UN, Obs.)  0.022  0.017  0.026
(KL(UN, Obs.) – KL(GNG, Obs.))/KL(UN, Obs.)  0.97  0.97  0.97
MCF7 : Raw
MCF7 : Normaized
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probes ﬂagged in the original data based on the 
model ﬁtted with the bootstrap sample. We then 
calculated the propor  tion of the hypermethylated 
loci that retained the same classiﬁcation as the 
originals, and referred to it as the rate of consis-
tency. We generated B = 200 bootstrap samples for 
each of the three experiments, which resulted in a 
mean consistency rate of 94.6, 98.4, and 99.0%, 
respectively.
3.3. Biological relevance 
of hypermethylated genes
For the given data set, the GNG model identiﬁes 
genes for which their promoter regions are hyper- 
as well as hypomethylated in the breast cancer cell 
lines. However, as our research focus is on genes 
down-regulated by DNA methylation, we will 
conﬁne our discussion con  cerning the biological 
relevance of the target genes only to the subset of 
hypermethylated genes.
Cancer cell lines are known to have more meth-
ylation events than primary tumors due to the effect 
of long-term culturing of DNA methylation. This 
is evident in the number of methylated genes 
identiﬁed by the GNG model in the breast cancer 
cell lines. T47D has many methylated genes 
(1,051), followed closely by MCF7 (965), and 
MDA-MB-361 has signiﬁcantly less methylated 
targets (375). This is equivalent to about 4–10% 
methylation as our microarray platform contains 
close to 11,000 unique genes. In primary breast 
tumors, we expect to detect around 1–2% meth-
ylation events. Of the genes ﬂagged to be hyper-
methylated, 86 of them are common in all three 
cell lines. The Venn diagram in Figure 4 also shows 
that MCF7 and T47D share 212 additional hyper-
methylated genes, which more than doubles that 
shared by MDAMB361 and either of these two cell 
lines. This ﬁnding is consistent with our discussion 
of the characteristics of the cell lines earlier in 
Section 3.1.
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Figure 3. Density plots and QQ plots of ﬁtted model. 
A–C: density plots of ﬁtted model superimposed on observed data histograms for each of the three datasets. D–F: QQ-plots of the ﬁtted 
model and the observed empirical distribution, for each of the three datasets51
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The Gene ontology tree machine (GOTM) 
Zhang et al. (2004) was used to conduct a statistical 
analysis of the GO terms enriched by the 86 
commonly methylated genes. Using the entire 
genome as the reference population, the category 
“Sequence-speciﬁc DNA binding” is enriched in 
this set (p-value = 0.0019). Of the seven genes 
(HOXB13, FALZ, FOXO3A, GATA2, HOXB9, 
HOXD11, and TERT ) present in this category, a 
couple of them deserve more detailed discussion. 
HOXB13 is a gene we have studied extensively 
before (Rodriguez et al. 2006). This gene encodes 
a transcription factor that belongs to the homeobox 
gene family. It was evaluated through quantitative 
methylation-speciﬁc PCR (qMSP) that higher level 
of methylation occurred in hormone-receptor posi-
tive primary breast tumors, corroborating our 
current microarray ﬁnding. Another sequence-
speciﬁc DNA binding gene identiﬁed is FALZ. The 
protein coded by FALZ is highly similar to the 
largest subunit of the Drosophila NURF (nucleo-
some remodeling factor) complex which interacts 
with sequence-speciﬁc transcription factors to 
facilitate gene transcription. There is evidence that 
human NURF complex can act as a negative regu-
lator of the JAK/STAT (cytokine signaling) 
pathway thereby decreasing growth rate and 
anchorage-independent growth of cancer cells. As 
such, hypermethylation of FALZ can confer growth 
advantage to these cell lines in many diverse ways. 
Another member of the sequence-speciﬁc DNA 
binding gene list, FOXO3A, belongs to the fork-
head family of transcription factors. This gene 
likely functions as a trigger for apoptosis through 
expression of genes necessary for cell death. There-
fore, for cell lines such as T47D that lacks caspase 3 
(Radisavljevic, 2003), the FOXO3a kinase 
pathway provides a much need means to trigger 
cellular apoptosis.
In addition to the GO analysis, we decided to verify 
the methylation status of some of the other genes. 
Genes were ﬁrst checked against the literature to 
establish that their suppression might play a role in 
cancer development and progression. Then a subset 
of genes with probes on BfaI fragment(s) that over-
lapped promoter CpG island were selected for valida-
tion by methylation-speciﬁc PCR in MCF7 cell lines 
(MSP) (Herman et al. 1996). Genes shown by MSP 
to be methylated are identiﬁed in Figure 3D as brown 
bullets. It is evident from the plot that the methylation 
MDAMB361
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585
Figure 4. Venn diagram denoting the intersection between the sets of hypermethylated genes for each of the three experiments. The radius 
of each circle is relative to the number of genes in each set.52
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levels of these gene targets varied from moderately 
methylated to highly methylated.
Yet another approach to evaluate hypermethyl-
ated genes identiﬁed by the GNG model is to seek 
out genes evaluated in other breast cancer studies. 
One such gene is LATS1. The GNG model identiﬁed 
this gene to be methylated in all three cell lines 
studied. Experimen  tal evidence suggests that this 
gene is a tumor suppressor gene capable of modu-
lating cell survival and negatively regulating cell 
proliferation by modulating CDC2/Cyclin A 
activity (Xia et al. 2002). Another gene found to 
be hypermethylated in MDA-MB-361 and T47D 
is ETV5, also known as ERM. ETV5 is a member 
of the superfamily of Ets-related tran  scription 
factors. Members of this family bind to related 
DNA sequence elements in the promoters of target 
genes to regulate gene transcription. Candidate 
target genes include ERBB2 (encodes Her2/neu) 
and genes encode matrix proteases (Bieche et al. 
2004). There fore, dysregulation of ETV5 (by DNA 
methylation) would lead to increase invasive 
potential of tumor cells. The observation of 
promoter hypermethylation in this gene in MDA-
MB-361 is reasonable as this cell line overex-
presses Her2/neu. Such observation in T47D but 
not in MCF7 is also reasonable as tumors occurring 
at a younger age (T47D originated from a 54 years 
old patient) tends to be more aggressive than 
tumors occurring at an older age (MCF7 originated 
from a 69 years old patient). Contrarily to ETV5, 
WT1 was found to be hypermethylated in MCF7 
and T47D but not in MDA-MB-361. The WT1 gene 
was origi  nally identiﬁed as a tumor suppressor 
gene responsible for Wilms’ tumor, a kidney 
neoplasm of childhood. Recent ﬁndings point to 
an oncogenic effect of WT1 in tumor types such as 
leukemia and breast cancer. In the breast cancer 
study, (Miyoshi et al. 2002) observed that a high 
expression of WT1 conferred a poor prognosis for 
breast cancer patients independent of other conven-
tional prognostic factors. Therefore, it is reasonable 
to observe methylation of WT1 promoter in the 
less aggressive MCF7 and T47D but not in the 
more aggressive MDA-MB-361 cell line.
4. Discussion
In this paper, we proposed a single slide data 
analysis model (GNG mixture model) for identi-
fying hypermethylated CpG islands loci based on 
methylation microarray data, and applied it to 
analyze data generated from three estrogen 
receptor-positive cell lines. From a statistical 
perspective, the model ﬁts the data well, and 
outperforms the NU mixture model of Dean and 
Raftery (2005) that was proposed for gene expres-
sion analysis. To get a rough idea on how the GNG 
model would perform for gene expression data and 
to further compare with the NU model for such 
data, the GNG model was used to ﬁt the gene 
expression data analyzed in Dean and Raftery 
(2005). In this preliminary study, the genes that 
were differentially expressed according to the NU 
mixture model were similarly classiﬁed by the 
GNG model (data not shown), although differences 
exist in some cases. These initial ﬁndings warrant 
further inquiry into the general applicability of the 
GNG model for classifying data obtained from 
various types of two-color arrays, but it is not 
within the scope of the current paper.
Through a bootstrap resampling technique, we 
evaluated the reliability of the loci that are ﬂagged 
as hypermethylated. For all three cell lines, the call 
consistency was at least close to 95% based on 
B = 200 bootstrap samples, which provided us with 
high conﬁdence in the loci labeled as hypermethyl-
ated. As discussed earlier regarding making infer-
ences on classifying a probe as hypermethylated, 
we suggested setting the strength-of-evidence 
constant C to be inversely proportional to the 
‘reliability’ of the microarray. Such a priori infor-
mation may be learned through a standard known 
test set. However, if such information is not readily 
available, then the bootstrap procedure might be 
applied to various constants C’s. The one that 
would lead to a high consistency rate could then 
be chosen for making inferences.
Four lines of evidence were sought to evaluate 
the biological relevance of the loci identi  ﬁed as 
hypermethylated among the three cell lines: the 
number of singularly and commonly (both two 
ways and three ways) methylated loci; the gene 
ontology analysis of the commonly methylated loci 
in all three cell lines; the experimental veriﬁcation 
of a subset of the ﬂagged loci using methylation-
speciﬁc PCR; and the literature supports of key 
methylated loci iden tiﬁed. Since the three cell lines 
are all estrogen receptor-positive with key simi-
larities, but there are also clear differences in their 
phenotypic characteristics, the results match well 
with such biological knowledge. The GNG model 
revealed that MCF7 and T47D cell lines had similar 
amount of hypermethylated genes whereas the cell 53
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line MDA-MB-361 had signiﬁ  cantly less methyl-
ated targets. At this global level, the GNG model 
portrays a relationship between DNA methylation 
and aging. A more aggressive tumor increases in 
severity quickly (such as MDA-MB-361) thereby 
progresses with little accumulation of methylation 
marks. Tumors from older patients (such as MCF7) 
develop less aggressively thereby accumulate more 
methylation events along the way. With the advent 
of microarray technology (current microarray 
platform interrogates close to 11,000 gene 
promoters), the GNG model uncovers many meth-
ylation events previously not described in the 
literature. We chose to validate a small set of genes 
identiﬁed as hypermethylated in MCF7. These 
genes had varying degree of methylation in 
comparison to immortalized normal breast epithe-
lial cell line MCF10A. This experimental outcome 
in part substantiates the usefulness of the GNG 
model. A sur  vey of the literature uncovers gene 
targets methylated concurrently or in a subset of 
the three breast cancer cell lines studied as 
described by other researchers. Methylation 
proﬁles of some of these genes are highlighted (not 
exhaustively) to provide additional support for 
these gene targets (black bullets in ﬁgure 2D).
It would also be of interest to evaluate the 
biological relevance of the methylated genes 
through its cross-correlation with gene expression 
data. To this end, we brieﬂy examined a few of the 
genes that are commonly assayed in both the 
Affymetrix gene expression array based on which 
the gene expression data on the same cell lines 
were generated and the 44 K methylation array. It 
appears that some of the genes that are hypermeth-
ylated are indeed down-regulated in their gene 
expression, but given the small number of genes 
examined, it is diffcult to draw any general conclu-
sion at this point. However, it would be of great 
interest to ﬁnd the genes that are both hypermeth-
ylated and down-regulated, as they might be 
potential biomarkers for cancer diagnosis, prog-
nosis, or even targets of demethylation drugs.
Finally, we note that although the GNG model 
was proposed for analyzing single slide methyla-
tion data due to the need for such a procedure, the 
formulation can be easily ex  tended to the analysis 
of multi-slide data. One possibility would simply 
be using the average normalized log ratios, 
following Dean and Raftery (2005). Another would 
use normalized (within and between slides) log 
ratios from each slide directly in the joint likeli-
hood formu  lation to increase the sample size and 
hence accuracy of the parameter estimates. Be it 
as a single-, or a multi-slide analysis tool, the GNG 
model can be used for data from other microarray 
platforms, such as gene expression data.
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